Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous CD34+ cells transfected with lentiviral vector containing the human arylsulfatase A cDNA

EU orphan designation number: EU/3/07/446   
Active ingredient: Autologous CD34+ cells transfected with lentiviral vector containing the human arylsulfatase A cDNA
Indication: Treatment of metachromatic leukodystrophy
Sponsor: Orchard Therapeutics Ltd
108 Cannon Street, London EC4N 6EU, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/04/2007 Orphan designation EMEA/OD/102/06 (2007)1769 of 13/04/2007
2/12/2009 Change of name and/or address of sponsor
11/10/2013 Change of name and/or address of sponsor
1/08/2014 Transfer of orphan designation EMA/OD/102/06/T/01 (2014)5574 of 30/07/2014
2/08/2018 Transfer of orphan designation EMA/OD/102/06/T/02 (2018)5287 of 31/07/2018